UBS Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $130
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsPrice Target
UBS analyst Patrick Wood maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $120 to $130.
UBS analyst Patrick Wood maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $120 to $130.